Market Cap 19.74M
Revenue (ttm) 0.00
Net Income (ttm) -55.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 297,616
Avg Vol 154,086
Day's Range N/A - N/A
Shares Out 35.14M
Stochastic %K 51%
Beta 2.97
Analysts Strong Sell
Price Target $7.33

Company Profile

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 410 0266
Address:
11250 El Camino Real, Suite 100, San Diego, United States
MissionaryTrader
MissionaryTrader Aug. 7 at 2:41 PM
$SKYE added
1 · Reply
Polsky
Polsky Aug. 7 at 1:40 PM
$SKYE pre-split price - $0,00184 Amazing deal people, load up before they go bankrupt hahahaha
0 · Reply
Jangalang
Jangalang Aug. 7 at 12:29 PM
$SKYE … 8th reverse split with another name change in the very near future.
0 · Reply
Polsky
Polsky Aug. 7 at 11:00 AM
$SKYE damn, should I add? loooooool
1 · Reply
Rascal7777777
Rascal7777777 Aug. 6 at 10:24 PM
$SKYE so this is just about gone too
2 · Reply
mdasti
mdasti Aug. 6 at 8:16 PM
$SKYE what happened
1 · Reply
MissionaryTrader
MissionaryTrader Aug. 6 at 8:09 PM
$SKYE looks like some people got burned setting a stop loss.
1 · Reply
Picklerinthekitchen
Picklerinthekitchen Aug. 5 at 8:48 PM
$SKYE Skye Bioscience (SKYE) is facing an investor securities lawsuit in the U.S. District Court for the Southern District of California, where shareholders allege that the company and related defendants participated in a fraudulent “pump-and-dump” scheme tied to the development of two drug candidates, NB1111 and nimacimab.
1 · Reply
MissionaryTrader
MissionaryTrader Aug. 5 at 4:20 PM
$SKYE added
0 · Reply
YazzJr
YazzJr Aug. 5 at 2:02 PM
$SKYE Looking at the volume, very clear investors are just sitting and waiting. Waiting for what? God only knows. Hopefully at their ER's CC they have something of substance to discuss.
1 · Reply
Latest News on SKYE
Skye Bioscience Transcript: AGM 2026

May 26, 2026, 1:00 PM EDT - 2 months ago

Skye Bioscience Transcript: AGM 2026


Skye Bioscience reports Q1 EPS (32c), consensus (32c)

2026-05-11T21:09:20.000Z - 3 months ago

Skye Bioscience reports Q1 EPS (32c), consensus (32c)


Skye Bioscience Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Skye Bioscience Quarterly report: Q1 2026


Skye Bioscience Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Skye Bioscience Earnings release: Q1 2026


Skye Bioscience Slides: Corporate presentation

May 11, 2026, 7:00 AM EDT - 3 months ago

Skye Bioscience Slides: Corporate presentation


Skye Bioscience Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Skye Bioscience Proxy statement: Proxy filing


Skye Bioscience Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Skye Bioscience Proxy statement: Proxy filing


Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit

Apr 7, 2026, 7:00 AM EDT - 4 months ago

Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit


Skye Bioscience Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Skye Bioscience Proxy statement: Proxy filing


Skye Bioscience Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Skye Bioscience Proxy statement: Proxy filing


Skye Bioscience Slides: Corporate presentation

Apr 3, 2026, 7:00 AM EDT - 4 months ago

Skye Bioscience Slides: Corporate presentation


Skye Bioscience Earnings Call Transcript: Q4 2025

Mar 10, 2026, 4:30 PM EDT - 5 months ago

Skye Bioscience Earnings Call Transcript: Q4 2025


Skye Bioscience Earnings release: Q4 2025

Mar 10, 2026, 4:30 PM EDT - 5 months ago

Skye Bioscience Earnings release: Q4 2025


Skye Bioscience Annual report: Q4 2025

Mar 10, 2026, 4:30 PM EDT - 5 months ago

Skye Bioscience Annual report: Q4 2025


Skye Bioscience Slides: Q4 2025

Mar 10, 2026, 4:30 PM EDT - 5 months ago

Skye Bioscience Slides: Q4 2025


Skye Bioscience reports Q4 EPS (36c), consensus (31c)

2026-03-10T20:12:08.000Z - 5 months ago

Skye Bioscience reports Q4 EPS (36c), consensus (31c)


Skye Bioscience Slides: Corporate presentation

Feb 21, 2026, 6:00 AM EST - 5 months ago

Skye Bioscience Slides: Corporate presentation


Skye Bioscience presents poster on efficacy of Nimacimab

2026-01-29T12:20:16.000Z - 6 months ago

Skye Bioscience presents poster on efficacy of Nimacimab


Skye Bioscience to Present Poster at Keystone Obesity Conference

Jan 21, 2026, 7:00 AM EST - 7 months ago

Skye Bioscience to Present Poster at Keystone Obesity Conference


Skye Bioscience provides 2026 corporate outlook

2026-01-12T12:12:34.000Z - 7 months ago

Skye Bioscience provides 2026 corporate outlook


Skye Provides 2026 Corporate Outlook

Jan 12, 2026, 7:00 AM EST - 7 months ago

Skye Provides 2026 Corporate Outlook


Skye Bioscience Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:30 PM EST - 9 months ago

Skye Bioscience Earnings Call Transcript: Q3 2025


Skye Bioscience Earnings release: Q3 2025

Nov 10, 2025, 4:30 PM EST - 9 months ago

Skye Bioscience Earnings release: Q3 2025


Skye Bioscience Quarterly report: Q3 2025

Nov 10, 2025, 4:30 PM EST - 9 months ago

Skye Bioscience Quarterly report: Q3 2025


Skye Bioscience reports Q3 EPS (32c), consensus (32c)

2025-11-10T21:16:34.000Z - 9 months ago

Skye Bioscience reports Q3 EPS (32c), consensus (32c)


Skye Bioscience downgraded to Hold from Buy at Craig-Hallum

2025-10-06T16:15:27.000Z - 10 months ago

Skye Bioscience downgraded to Hold from Buy at Craig-Hallum


Why Is Skye Bioscience Stock Down 60% Today?

2025-10-06T12:19:20.000Z - 10 months ago

Why Is Skye Bioscience Stock Down 60% Today?


Skye Bioscience Transcript: Study Update

Oct 6, 2025, 8:00 AM EDT - 10 months ago

Skye Bioscience Transcript: Study Update


Skye Bioscience Press release: Study Update

Oct 6, 2025, 8:00 AM EDT - 10 months ago

Skye Bioscience Press release: Study Update


Skye Bioscience Slides: Study Update

Oct 6, 2025, 8:00 AM EDT - 10 months ago

Skye Bioscience Slides: Study Update


Skye Bioscience Slides: Corporate Presentation

Sep 10, 2025, 7:00 AM EDT - 11 months ago

Skye Bioscience Slides: Corporate Presentation


Skye Bioscience Transcript: KOL Event

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Skye Bioscience Transcript: KOL Event


Skye Bioscience Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Skye Bioscience Earnings Call Transcript: Q2 2025


Skye Bioscience Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Skye Bioscience Quarterly report: Q2 2025


Skye Bioscience Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Skye Bioscience Earnings release: Q2 2025


Skye Bioscience Slides: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Skye Bioscience Slides: Q2 2025


MissionaryTrader
MissionaryTrader Aug. 7 at 2:41 PM
$SKYE added
1 · Reply
Polsky
Polsky Aug. 7 at 1:40 PM
$SKYE pre-split price - $0,00184 Amazing deal people, load up before they go bankrupt hahahaha
0 · Reply
Jangalang
Jangalang Aug. 7 at 12:29 PM
$SKYE … 8th reverse split with another name change in the very near future.
0 · Reply
Polsky
Polsky Aug. 7 at 11:00 AM
$SKYE damn, should I add? loooooool
1 · Reply
Rascal7777777
Rascal7777777 Aug. 6 at 10:24 PM
$SKYE so this is just about gone too
2 · Reply
mdasti
mdasti Aug. 6 at 8:16 PM
$SKYE what happened
1 · Reply
MissionaryTrader
MissionaryTrader Aug. 6 at 8:09 PM
$SKYE looks like some people got burned setting a stop loss.
1 · Reply
Picklerinthekitchen
Picklerinthekitchen Aug. 5 at 8:48 PM
$SKYE Skye Bioscience (SKYE) is facing an investor securities lawsuit in the U.S. District Court for the Southern District of California, where shareholders allege that the company and related defendants participated in a fraudulent “pump-and-dump” scheme tied to the development of two drug candidates, NB1111 and nimacimab.
1 · Reply
MissionaryTrader
MissionaryTrader Aug. 5 at 4:20 PM
$SKYE added
0 · Reply
YazzJr
YazzJr Aug. 5 at 2:02 PM
$SKYE Looking at the volume, very clear investors are just sitting and waiting. Waiting for what? God only knows. Hopefully at their ER's CC they have something of substance to discuss.
1 · Reply
Yahtzee27
Yahtzee27 Aug. 3 at 1:48 PM
$SKYE bbq chicken…. Unfortunately
0 · Reply
Blinddartthrowerl
Blinddartthrowerl Aug. 1 at 7:15 PM
$SKYE. Whats it going to be RS or News Catalyst? “If the Company chooses to implement a reverse stock split, it must complete the split no later than ten business days prior to September 14, 2026, to regain compliance.” The filing also says that “if SKYE gets its closing bid back to $1.00 or higher for 10 consecutive business days before the deadline, Nasdaq will confirm compliance—meaning no reverse split would be necessary.”
1 · Reply
laborer75
laborer75 Jul. 31 at 3:09 PM
$SKYE Nibbling a bit here. A lotto ticket at this point. 🤞
1 · Reply
MissionaryTrader
MissionaryTrader Jul. 31 at 1:34 PM
$SKYE added
1 · Reply
Fellforit
Fellforit Jul. 30 at 6:25 PM
$SKYE come on missionary buyer..
1 · Reply
MissionaryTrader
MissionaryTrader Jul. 30 at 4:58 PM
$SKYE biotech stocks are not for everyone. Several investors who used to be on this feed sold and invested in CAPR (another biotech). Last December, that stock went from around $5 to $40 earlier this year. In the last few weeks it dropped from over $30 to $3 today. Similar to what we’ve experienced with SKYE. This quarter and the next will determine if the 6 year wait and money spent on SKYE was worth it for me or if this will be one of the most expensive lessons of my life. Not much longer.
3 · Reply
MissionaryTrader
MissionaryTrader Jul. 27 at 2:50 PM
$SKYE added
1 · Reply
Fellforit
Fellforit Jul. 24 at 6:54 PM
$SKYE sue them again...
0 · Reply
MissionaryTrader
MissionaryTrader Jul. 23 at 11:45 PM
$SKYE https://www.tipranks.com/news/class-action/skye-bioscience-lawsuit-company-and-ceo-move-to-dismiss-claims
2 · Reply
Fellforit
Fellforit Jul. 22 at 9:11 PM
$SKYE shes ready to blow..
1 · Reply
Blinddartthrowerl
Blinddartthrowerl Jul. 22 at 12:50 AM
$SKYE When is the RS?
1 · Reply
YazzJr
YazzJr Jul. 16 at 12:42 PM
$SKYE Interesting pre-market until you look at the amount of shares traded, 1004. But hey, at least we are going in the right direction.
1 · Reply